This course delves into the core pharmacological strategies for managing heart failure with reduced ejection fraction (HFrEF). With evolving guidelines and evidence-based advancements, it focuses on the “4 pillars” of pharmacotherapy that have revolutionized HFrEF treatment. Designed for healthcare professionals, the program provides a clear roadmap for initiating and optimizing these therapies to improve patient outcomes.